+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 50 Pages
  • July 2022
  • GlobalData
  • Novan Inc.
  • ID: 4395061
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


Novan Inc (Novan) is a clinical development-stage biotechnology company that focuses on leveraging nitric oxide’s immunomodulatory and anti-microbial mechanisms of action for the treatment of diseases with unmet needs. The company’s products find application in the treatment of dermatology disorders, gastroenterology and women’s health. Its pipeline products focus on treating acne vulgaris, external genital warts, onychomycosis, psoriasis, molluscum, tinea pedis, human papillomavirus (HPV) and atopic dermatitis. Novan uses its proprietary technology Nitricil to develop new chemical entities with sustained delivery of nitric oxide. It works in Collaboration with academic institutions, Universities, private and public companies. Novan is headquartered in Morrisville, North Carolina, the US.

Novan Inc Key Recent Developments


May 16, 2022: Novan Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 06, 2022: Novan to Report First Quarter 2022 Financial Results on May 16, 2022
Apr 20, 2022: Novan to Participate in the Virtual Investor Innovation in Dermatology Spotlight Event
Feb 22, 2022: Novan Reports Full Year 2021 Financial Results and Provides Corporate Update
Feb 15, 2022: Novan to Report Full Year 2021 Financial Results on February 22, 2022

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Novan Inc - Key Facts
  • Novan Inc - Key Employees
  • Novan Inc - Key Employee Biographies
  • Novan Inc - Major Products and Services
  • Novan Inc - History
  • Novan Inc - Company Statement
  • Novan Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Novan Inc - Business Description
  • Business Segment: Government Research Contracts and Grants
  • Performance
  • Business Segment: License and collaboration
  • Performance
  • R&D Overview
  • Novan Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Novan Inc - Strengths
  • Novan Inc - Weaknesses
  • Novan Inc - Opportunities
  • Novan Inc - Threats
  • Novan Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Novan Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 16, 2022: Novan Reports First Quarter 2022 Financial Results and Provides Corporate Update
  • May 06, 2022: Novan to Report First Quarter 2022 Financial Results on May 16, 2022
  • Apr 20, 2022: Novan to Participate in the Virtual Investor Innovation in Dermatology Spotlight Event
  • Feb 22, 2022: Novan Reports Full Year 2021 Financial Results and Provides Corporate Update
  • Feb 15, 2022: Novan to Report Full Year 2021 Financial Results on February 22, 2022
  • Nov 12, 2021: Novan to Participate in the Virtual Investor Roundtable Event
  • Nov 03, 2021: Novan to Report Third Quarter 2021 Financial Results on November 10, 2021
  • Nov 02, 2021: Novan Appoints Brian M. Johnson as Chief Commercial Officer
  • Sep 20, 2021: Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
  • Sep 07, 2021: Novan to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Novan Inc, Key Facts
  • Novan Inc, Key Employees
  • Novan Inc, Key Employee Biographies
  • Novan Inc, Major Products and Services
  • Novan Inc, History
  • Novan Inc, Subsidiaries
  • Novan Inc, Key Competitors
  • Novan Inc, Ratios based on current share price
  • Novan Inc, Annual Ratios
  • Novan Inc, Interim Ratios
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Novan Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Novan Inc, Performance Chart (2017 - 2021)
  • Novan Inc, Ratio Charts
  • Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Novan Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ImmunoGen Inc
  • Melinta Therapeutics Inc
  • Helix BioMedix Inc
  • Mycovia Pharmaceuticals Inc
  • AnaptysBio Inc
  • Vaxart Inc